1 – 10 of 207
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Associations between structural brain changes and blood neurofilament light chain protein in treatment-resistant schizophrenia
- Contribution to journal › Article
-
Mark
APOE4 impact on soluble and insoluble tau pathology is mostly influenced by amyloid-beta
- Contribution to journal › Article
-
Mark
The Alzheimer's Association Global Biomarker Standardization Consortium (GBSC) plasma phospho-tau Round Robin study
- Contribution to journal › Article
-
Mark
Plasma phosphorylated tau217 strongly associates with memory deficits in the Alzheimer's disease spectrum
- Contribution to journal › Article
-
Mark
Alpha-synuclein seed amplification assay longitudinal outcomes in Lewy body disease spectrum
- Contribution to journal › Article
-
Mark
Quantification of Lewy body pathology by cerebrospinal fluid endpoint dilution RT-QuIC in a neuropathological autopsy cohort of clinically heterogeneous participants
- Contribution to journal › Article
-
Mark
Combining plasma p-tau217 and cross-cultural cognitive tests to identify Alzheimer's Disease in an ethnically diverse mixed memory clinic cohort
- Contribution to journal › Article
-
Mark
Evaluation of a Sensitive Visual Read Algorithm for Assessing 3R/4R Tau PET Images
(2025) In Journal of nuclear medicine : official publication, Society of Nuclear Medicine 66(11). p.1764-1770
- Contribution to journal › Article
-
Mark
A comprehensive head-to-head comparison of key plasma phosphorylated tau 217 biomarker tests
- Contribution to journal › Article
-
Mark
Prediction of continuous amyloid positron emission tomography with fluid measures of phosphorylated tau and β-amyloid
(2025) In EMBO Molecular Medicine
- Contribution to journal › Article
